Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mol Immunol. 2013 Dec;56(4):599-611. doi: 10.1016/j.molimm.2013.06.005. Epub 2013 Aug 1.
Nowadays many therapeutic agents such as suicide genes, anti-angiogenesis agents, cytokines, chemokines and other therapeutic genes were delivered to cancer cells. Various biological delivery systems have been applied for directing therapeutic gene to target cells. Some of these successful preclinical studies, steps forward to clinical trials and a few are examined in phase III clinical trials. In this review, the biological gene delivery systems were categorized into microorganism and cell based delivery systems. Viral, bacterial, yeast and parasite are among microorganism based delivery systems which are expanded in this review. In cell based approach, different strategies such as tumor cells, stem cells, dendritic cells and sertoli cells will be discussed. Different drawbacks are associated with each delivery system; therefore, many strategies have been improved and potentiated their direction toward specific target cells. Herein, further to the principle of each delivery system, the progresses of these approaches for development of newer generation are discussed.
如今,许多治疗剂,如自杀基因、抗血管生成剂、细胞因子、趋化因子和其他治疗基因,已被递送到癌细胞中。各种生物传递系统已被应用于将治疗基因靶向靶细胞。其中一些成功的临床前研究已经进入临床试验阶段,还有一些正在进行三期临床试验。在这篇综述中,生物基因传递系统被分为基于微生物和细胞的传递系统。病毒、细菌、酵母和寄生虫是基于微生物的传递系统的一部分,在本文中进行了扩展。在基于细胞的方法中,将讨论不同的策略,如肿瘤细胞、干细胞、树突状细胞和睾丸支持细胞。每种传递系统都有其自身的缺点,因此,许多策略都得到了改进,并加强了它们对特定靶细胞的靶向性。在此,本文在介绍每种传递系统原理的基础上,进一步讨论了这些方法在开发新一代基因传递系统方面的进展。